Evaluation of Visual Acuity Improvement of a PRN Regimen Using Ranibizumab for Macular Edema Due to Ischemic and Non- Ischemic Branch Retinal Vein Occlusion
Phase of Trial: Phase IV
Latest Information Update: 25 Oct 2016
At a glance
- Drugs Ranibizumab (Primary)
- Indications Retinal oedema
- Focus Therapeutic Use
- 19 Oct 2016 Planned End Date changed from 1 Sep 2018 to 1 Sep 2019.
- 19 Oct 2016 Planned primary completion date changed from 1 Apr 2018 to 1 Mar 2019.
- 06 Apr 2016 Planned End Date changed from 1 Sep 2017 to 1 Sep 2018 as reported by ClinicalTrials.gov record.